Clinical Trial Update: Effect of Reslizumab in Chronic Rhinosinusitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for reslizumab in chronic sinusitis (sinusitis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sinusitis

Drugs mentioned

• reslizumab (reslizumab)

Snippet

Sponsor: Joshua S. Jacobs | Conditions: Sinusitis | Phase 3 | Status: UNKNOWN